Biosynthetic Technologies
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $14.7m | Early VC | |
N/A | Early VC | ||
$100m | Debt | ||
N/A | Acquisition | ||
$9.5m | Series A | ||
* | $7.5m Valuation: $47.5m | Series A | |
Total Funding | CAD43.2m |
Related Content
Recent News about Biosynthetic Technologies
EditBiosynthetic Technologies specializes in the production of biobased synthetic compounds known as estolides, derived from organic fatty acids found in various bio-derived oils. These compounds are designed to meet the evolving needs of the Beauty and Personal Care industry, as well as applications in lubricants, automotive, marine, and industrial sectors. The company operates in the sustainable manufacturing market, emphasizing environmental responsibility by minimizing negative impacts and conserving natural resources. Biosynthetic Technologies serves a diverse range of clients, including manufacturers in the personal care, automotive, and industrial sectors. The business model revolves around the production and sale of high-performance, biodegradable, and renewable estolides, generating revenue through direct sales and partnerships. The company's commitment to sustainability and innovation positions it as a leader in the biobased synthetic compounds market.
Keywords: biobased, estolides, sustainable, personal care, lubricants, automotive, marine, biodegradable, renewable, high-performance.